CytomX Therapeutics is committed to changing the treatment of cancer with their novel PROBODY therapeutic platform.
CytomX Therapeutics is seeking a Senior Scientist I/II, Bioconjugation to join their team. The successful candidate will be responsible for developing robust research scale conjugation processes, novel conjugation strategies, and analytical methods to support the discovery pipeline PDC programs.
CytomX Therapeutics is committed to changing the treatment of cancer with their novel PROBODY therapeutic platform.
Dyne Therapeutics